title: Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.
abstract: Candida albicans is a yeast-like pathogen and can cause life-threatening systemic candidiasis. Its cell surface is enriched with mannan that is resistant to complement activation. Previously, we developed the recombinant human IgG1 antimannan antibody M1g1. M1g1 was found to promote complement activation and phagocytosis and protect mice from systemic candidiasis. Here, we evaluate the influence of IgG subclass on antimannan antibody-mediated protection. Three IgG subclass variants of M1g1 were constructed: M1g2, M1g3, and M1g4. The IgG subclass identity for each variant was confirmed with DNA sequence and subclass-specific antibodies. These variants contain identical M1 Fabs and exhibited similar binding affinities for C. albicans yeast and purified mannan. Yeast cells and hyphae recovered from the kidney of antibody-treated mice with systemic candidiasis showed uniform binding of each variant, indicating constitutive expression of the M1 epitope and antibody opsonization in the kidney. All variants promoted deposition of both murine and human C3 onto the yeast cell surface, with M1g4 showing delayed activation, as determined by flow cytometry and immunofluorescence microscopy. M1g4-mediated complement activation was found to be associated with its M1 Fab that activates the alternative pathway in an Fc-independent manner. Treatment with each subclass variant extended the survival of mice with systemic candidiasis (P < 0.001). However, treatment with M1g1, M1g3, or M1g4, but not with M1g2, also reduced the kidney fungal burden (P < 0.001). Thus, the role of human antimannan antibody in host resistance to systemic candidiasis is influenced by its IgG subclass.
authors.affiliation: Department of Biological Sciences, California State University, Long Beach, California, USA.
authors.forename: Casey T
authors.initials: CT
authors.lastname: Nishiya
authors.affiliation: Department of Biological Sciences, California State University, Long Beach, California, USA.
authors.forename: Gayle M
authors.initials: GM
authors.lastname: Boxx
authors.affiliation: Department of Biological Sciences, California State University, Long Beach, California, USA.
authors.forename: Kerry
authors.initials: K
authors.lastname: Robison
authors.affiliation: Department of Biological Sciences, California State University, Long Beach, California, USA.
authors.forename: Carol
authors.initials: C
authors.lastname: Itatani
authors.affiliation: Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, Nevada, USA.
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Kozel
authors.affiliation: Department of Biological Sciences, California State University, Long Beach, California, USA mason.zhang@csulb.edu.
authors.forename: Mason X
authors.initials: MX
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000908:Antibodies, Fungal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D001666:Binding Sites, Antibody; D002176:Candida albicans / Q000276:immunology* / Q000302:isolation & purification / Q000648:ultrastructure; D058365:Candidiasis, Invasive / Q000276:immunology* / Q000517:prevention & control* / Q000628:therapy; D003167:Complement Activation; D003176:Complement C3 / Q000276:immunology / Q000378:metabolism; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007140:Immunoglobulin Fab Fragments / Q000235:genetics / Q000276:immunology; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000145:classification / Q000276:immunology* / Q000627:therapeutic use; D007668:Kidney / Q000382:microbiology*; D008351:Mannans / Q000276:immunology*; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000908:Antibodies, Fungal; D003176:Complement C3; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D008351:Mannans; D011994:Recombinant Proteins